Topic: AI/Technology Solution
Feasible but Fragile: MindBench.ai and the Path to Responsible AI in Mental Health
Dr. John Torous discusses how AI in mental health is “feasible but fragile” and how MindBench.ai is being developed to ensure patient-centered, safe, and effective innovation.
Responsible AI for Youth Mental Health; What We Are Learning and What Must Change
Localized Crisis Helplines Integrated into ChatGPT and Sora
ChatGPT and Sora now offer localized crisis helplines, providing immediate, confidential support and ensuring human intervention remains available for those experiencing severe distress.
Whakarongorau, New Zealand’s National Telehealth Provider, Advances Mental Health Access With AI Concierge Platform
Whakarongorau, New Zealand’s national telehealth provider, is developing an AI-enabled concierge platform to simplify navigation, enable earlier intervention, and improve equitable access to mental health and addiction support.
Flow Neuroscience tDCS Headset Approved in Australia, Expanding Access to Evidence-Based Depression Treatment
Flow Neuroscience’s tDCS headset for depression has received TGA approval in Australia, providing a safe, at-home, evidence-based treatment option and expanding access to non-medication mental health care.
OpenAI’s Curated Therapist Network Set to Accelerate Global Demand for Mental Health Professionals
OpenAI’s new curated network of therapists, integrated with ChatGPT, could dramatically increase global demand for mental health professionals by providing seamless, immediate access to qualified support.
uSupport – a New Psychological Support Platform for Young People from Poland and Ukraine
uSupport, a UNICEF-supported online psychological support platform for Polish and Ukrainian youth, has launched its pilot in Poland to provide accessible, culturally tailored mental health assistance for young people aged 16–24.
OpenAI Updates ChatGPT to Improve Handling of Sensitive Mental Health Conversations
OpenAI has updated ChatGPT since August 2025 to improve its handling of sensitive mental health conversations, introducing safeguards for distress, self-harm, psychosis, and emotional reliance, with subsequent updates including GPT‑5.1 maintaining and expanding these safety measures.
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
Major Report Maps UK’s Extended Reality (XR) Health Market
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 12 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
